|
1
|
Gu L, Xu Y, Xu W, Li M, Su H, Li C and Liu
Z: The exosome secretion inhibitor neticonazole suppresses
intestinal dysbacteriosis-induced tumorigenesis of colorectal
cancer. Invest New Drugs. 38:221–228. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fidler MM and Bray F: Global cancer
inequalities. Front Oncol. 8:2932018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hong J, Lu H, Meng X, Ryu JH, Hara Y and
Yang CS: Stability, cellular uptake, biotransformation, and efflux
of tea polyphenol (−)-epigallocatechin-3-gallate in HT-29 human
colon adenocarcinoma cells. Cancer Res. 62:7241–7246.
2002.PubMed/NCBI
|
|
4
|
Araghi M, Soerjomataram I, Bardot A,
Ferlay J, Cabasag CJ, Morrison DS, De P, Tervonen H, Walsh PM,
Bucher O, et al: Changes in colorectal cancer incidence in seven
high-income countries: A population-based study. Lancet
Gastroenterol Hepatol. 4:511–518. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tsukuda K, Tanino M, Soga H, Shimizu N and
Shimizu K: A novel activating mutation of the K-ras gene in human
primary colon adenocarcinoma. Biochem Biophys Res Commun.
278:653–658. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wapinski O and Chang HY: Long noncoding
RNAs and human disease. Trends Cell Biol. 21:354–361. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang KC and Chang HY: Molecular mechanisms
of long noncoding RNAs. Mol Cell. 43:904–914. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Deng H, Wang JM, Li M, Tang R, Tang K, Su
Y, Hou Y and Zhang J: Long non-coding RNAs: New biomarkers for
prognosis and diagnosis of colon cancer. Tumour Biol. Jun
23–2017.(Epub ahead of print). View Article : Google Scholar
|
|
10
|
Cheng B, Rong A, Zhou Q and Li W: LncRNA
LINC00662 promotes colon cancer tumor growth and metastasis by
competitively binding with miR-340-5p to regulate CLDN8/IL22
co-expression and activating ERK signaling pathway. J Exp Clin
Cancer Res. 39:52020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu T, Wu K and Zhang L, Zheng S, Wang X,
Zuo H, Wu X, Tao G, Jiang B and Zhang L: Long non-coding RNA
LINC00858 exerts a tumor-promoting role in colon cancer via HNF4α
and WNK2 regulation. Cell Oncol (Dordr). 43:297–310. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang H, Huang H, Xu X, Wang H, Wang J,
Yao Z, Xu X, Wu Q and Xu F: LncRNA HCG11 promotes proliferation and
migration in gastric cancer via targeting miR-1276/CTNNB1 and
activating Wnt signaling pathway. Cancer Cell Int. 19:3502019.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen Y, Bao C, Zhang X, Lin X, Huang H and
Wang Z: Long non-coding RNA HCG11 modulates glioma progression
through cooperating with miR-496/CPEB3 axis. Cell Prolif.
52:e126152019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang YC, He WY, Dong CH, Pei L and Ma YL:
lncRNA HCG11 regulates cell progression by targeting miR-543 and
regulating AKT/mTOR pathway in prostate cancer. Cell Biol Int.
43:1453–1462. 2019. View Article : Google Scholar
|
|
15
|
Greenburg G and Hay ED: Epithelia
suspended in collagen gels can lose polarity and express
characteristics of migrating mesenchymal cells. J Cell Biol.
95:333–339. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Skrypek N, Goossens S, De Smedt E,
Vandamme N and Berx G: Epithelial-to-mesenchymal transition:
Epigenetic reprogramming driving cellular plasticity. Trends Genet.
33:943–959. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Loric S, Paradis V, Gala JL, Berteau P,
Bedossa P, Benoit G and Eschwège P: Abnormal E-cadherin expression
and prostate cell blood dissemination as markers of biological
recurrence in cancer. Eur J Cancer. 37:1475–1481. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sato M, Shames DS and Hasegawa Y: Emerging
evidence of epithelial-to-mesenchymal transition in lung
carcinogenesis. Respirology. 17:1048–1059. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qiu E, Gao Y, Zhang B, Xia T, Zhang Z and
Shang G: Upregulation of cell division cycle 20 in cisplatin
resistance-induced epithelial-mesenchymal transition in
osteosarcoma cells. Am J Transl Res. 12:1309–1318. 2020.PubMed/NCBI
|
|
20
|
Ye Y, Gu J, Liu P, Wang H, Jiang L, Lei T,
Yu S, Han G and Wang Z: Long non-coding RNA SPRY4-IT1 reverses
cisplatin resistance by downregulating MPZL-1 via suppressing EMT
in NSCLC. OncoTargets Ther. 13:2783–2793. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Acikgoz E, Tatar C and Oktem G: Triptolide
inhibits CD133+/CD44+ colon cancer stem cell
growth and migration through triggering apoptosis and represses
epithelial-mesenchymal transition via downregulating expressions of
snail, slug, and twist. J Cell Biochem. 121:3313–3324. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Eberhardt W, Nasrullah U and Haeussler K:
Inhibition of Caspase-2 translation by the mRNA binding protein
HuR: A novel path of therapy resistance in colon carcinoma Cells?
Cells. 8:E7972019. View Article : Google Scholar
|
|
25
|
Paldino E, Tesori V, Casalbore P,
Gasbarrini A and Puglisi MA: Tumor initiating cells and
chemoresistance: Which is the best strategy to target colon cancer
stem cells? BioMed Res Int. 2014:8598712014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kozovska Z, Gabrisova V and Kucerova L:
Colon cancer: Cancer stem cells markers, drug resistance and
treatment. Biomed Pharmacother. 68:911–916. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Uppada SB, Gowrikumar S, Ahmad R, Kumar B,
Szeglin B, Chen X, Smith JJ, Batra SK, Singh AB and Dhawan P: MASTL
induces colon cancer progression and chemoresistance by promoting
Wnt/β-catenin signaling. Mol Cancer. 17:1112018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Frankiewicz Z and Leski J: Adaptive
fiducial point detector for ECG stress testing systems. Int J
Biomed Comput. 28:127–135. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Qi X, Zhang DH, Wu N, Xiao JH, Wang X and
Ma W: ceRNA in cancer: Possible functions and clinical
implications. J Med Genet. 52:710–718. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chan JJ and Tay Y: Noncoding RNA: RNA
Regulatory Networks in Cancer. Int J Mol Sci. 19:E13102018.
View Article : Google Scholar
|
|
31
|
Cao TH, Ling X, Chen C, Tang W, Hu DM and
Yin GJ: Role of miR-214-5p in the migration and invasion of
pancreatic cancer cells. Eur Rev Med Pharmacol Sci. 22:7214–7221.
2018.PubMed/NCBI
|
|
32
|
Zheng C, Guo K, Chen B, Wen Y and Xu Y:
miR-214-5p inhibits human prostate cancer proliferation and
migration through regulating CRMP5. Cancer Biomark. 26:193–202.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang M, Wang D, Zhu T and Yin R:
miR-214-5p targets ROCK1 and suppresses proliferation and invasion
of human osteosarcoma cells. Oncol Res. 25:75–81. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ding L, Zhao Y, Dang S, Wang Y, Li X, Yu
X, Li Z, Wei J, Liu M and Li G: Circular RNA circ-DONSON
facilitates gastric cancer growth and invasion via NURF complex
dependent activation of transcription factor SOX4. Mol Cancer.
18:452019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hanieh H, Ahmed EA, Vishnubalaj R and
Alajez NM: SOX4: Epigenetic regulation and role in tumorigenesis.
Semin Cancer Biol. 67:91–104. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Grimm D, Bauer J, Wise P, Krüger M,
Simonsen U, Wehland M, Infanger M and Corydon TJ: The role of SOX
family members in solid tumours and metastasis. Semin Cancer Biol.
67:122–153. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lin CM, Fang CL, Hseu YC, Chen CL, Wang
JW, Hsu SL, Tu MD, Hung ST, Tai C, Uen YH, et al Clinical
prognostic implications of transcription factor SOX4 in patients
with colon cancer, : Clinical and prognostic implications of
transcription factor SOX4 in patients with colon cancer. PLoS One.
8:e671282013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shibue T and Weinberg RA: EMT, CSCs, and
drug resistance: The mechanistic link and clinical implications.
Nat Rev Clin Oncol. 14:611–629. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Du B and Shim JS: Targeting
epithelial-mesenchymal transition (EMT) to overcome drug resistance
in cancer. Molecules. 21:E9652016. View Article : Google Scholar
|
